ArticleScientific reports2026
DMEK grafts prepared from corneas stored in TISSUE-C and CARRY-C (deswelling medium) show similar viable endothelial cell density.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The potential cytotoxicity of dextran in deswelling media for DMEK graft preparation remains controversial. This study compared endothelial viability and viable endothelial cell density (vECD) in paired deswelled and control (non-deswelled) corneas. Eight pairs of human corneas were preserved in TISSUE-C (standard organ culture medium). Baseline endothelial cell densities (ECD1, ECD2) at two time points were equivalent. Two days before DMEK preparation, one cornea from each pair was transferred to CARRY-C (6% dextran deswelling medium), while its pair remained in TISSUE-C (control). On the preparation day, ECD3 was measured. Viability (percentage of viable endothelial areas) and vECD were determined by Hoechst-33,342/Calcein-AM staining, and cell morphology was assessed with CD166 immunofluorescence. ECD3 was higher in control corneas than in deswelled corneas (2150 ± 737 vs. 1708 ± 745 cells/mm², p = 0.0176), confirmed by Hoechst-based ECD (2025 ± 723 vs. 1775 ± 706, p = 0.0167). Viability was significantly higher in deswelled corneas (78% vs. 96%, p = 0.0013), yielding comparable vECD between groups (1628 ± 715 vs. 1712 ± 723, p = 0.3733). Non-viable areas in control corneas corresponded to endothelial folds from corneal edema. Deswelling markedly reduced folds, and cell migration from viable to non-viable areas was observed, explaining the lower ECD after deswelling. In conclusion, short-term deswelling lowers the measured ECD but does not reduce the total number of viable endothelial cells. The apparent decrease reflects cell migration from viable areas to cover the entire endothelial surface. These findings support the safety of dextran-based deswelling media for DMEK graft preparation and likely apply to penetrating keratoplasty as well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.